First Trust Advisors LP Cyclerion Therapeutics, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$3.46 - $8.39 $109,754 - $266,139	-31,721 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$2.37 - $7.14 $6,029 - $18,164	2,544 Added 8.72%	31,721 $187,000
Q1 2020 May 06, 2020	SELL	$2.46 - $5.84 $13,923 - $33,054	-5,660 Reduced 16.25%	29,177 $77,000
Q4 2019 Feb 03, 2020	SELL	$1.8 - $13.43 $1,116 - $8,326	-620 Reduced 1.75%	34,837 $95,000
Q3 2019 Nov 04, 2019	BUY	$8.12 - $14.54 $287,910 - $515,544	35,457 New	35,457 $430,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.